These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 6807240)
1. [Clinical study of prostacyclin in extracorporeal circulation. Effects on hemodynamics and coagulation]. Fabiani JN; Bunting S; Terrier E; O'Grady J; Fontaine B; Prigent C; Carpentier A; Vane J; Dubost C Arch Mal Coeur Vaiss; 1982 Mar; 75(3):241-8. PubMed ID: 6807240 [TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations. Fish KJ; Sarnquist FH; van Steennis C; Mitchell RS; Hilberman M; Jamieson SW; Linet OI; Miller DC J Thorac Cardiovasc Surg; 1986 Mar; 91(3):436-42. PubMed ID: 3512919 [TBL] [Abstract][Full Text] [Related]
4. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin. Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736 [TBL] [Abstract][Full Text] [Related]
5. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass. Coppe D; Sobel M; Seamans L; Levine F; Salzman E J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550 [TBL] [Abstract][Full Text] [Related]
6. [Effects of prostacyclin (PGI2) on tachycardic heart arrhythmias following aortocoronary venous bypass operations]. Heinrich D; Wagner WL; Höge R Herz; 1985 Dec; 10(6):357-65. PubMed ID: 3936760 [TBL] [Abstract][Full Text] [Related]
7. Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass. Comparison of a thromboxane synthetase inhibitor and a prostacyclin analogue. Huddleston CB; Hammon JW; Wareing TH; Lupinetti FM; Clanton JA; Collins JC; Bender HW J Thorac Cardiovasc Surg; 1985 Feb; 89(2):190-5. PubMed ID: 2578591 [TBL] [Abstract][Full Text] [Related]
8. Effect of PGI2 infusion during long term extracorporeal circulation with membrane lung in sheep. Uziel L; Agostoni A; Pirovano E; Pesenti A; Pelizzola A; Gattinoni L; Galmarini D Int J Artif Organs; 1981 May; 4(3):142-5. PubMed ID: 7024139 [TBL] [Abstract][Full Text] [Related]
9. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration. Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998 [TBL] [Abstract][Full Text] [Related]
10. The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass. Muriithi EW; Belcher PR; Rao JN; Chaudhry MA; Nicol D; Wheatley DJ J Thorac Cardiovasc Surg; 2000 Sep; 120(3):538-43. PubMed ID: 10962416 [TBL] [Abstract][Full Text] [Related]
11. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery. Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396 [TBL] [Abstract][Full Text] [Related]
12. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost. Palatianos GM; Foroulis CN; Vassili MI; Matsouka P; Astras GM; Kantidakis GH; Iliopoulou E; Melissari EN J Thorac Cardiovasc Surg; 2004 Feb; 127(2):548-54. PubMed ID: 14762367 [TBL] [Abstract][Full Text] [Related]
13. [Experimental studies on platelet preservation with prostaglandin I2 and its derivative (OP-41483) during cardiopulmonary bypass]. Takeda H Hokkaido Igaku Zasshi; 1989 Jul; 64(4):500-11. PubMed ID: 2511131 [TBL] [Abstract][Full Text] [Related]
15. Dissociation between hemodynamic and platelet antiaggregant effects of prostacyclin in dogs determined with a rapid platelet isolation technique. Czer GT; Moser KM J Lab Clin Med; 1983 Jul; 102(1):133-9. PubMed ID: 6343535 [TBL] [Abstract][Full Text] [Related]
16. [Hemodynamics and changes in compliance of the extra-thoracic capacity system following administration of prostacyclin (PGI2)]. Kramer M; Schleussner E; Schmidt A; Heinrich D; Walter P; Hempelmann G Herz; 1984 Apr; 9(2):102-9. PubMed ID: 6370814 [TBL] [Abstract][Full Text] [Related]
17. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2). van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057 [No Abstract] [Full Text] [Related]